Patents by Inventor Prabhavathi B. Fernandes

Prabhavathi B. Fernandes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biodefenses using triazole-containing macrolides
    Patent number: 9072759
    Abstract: Use of macrolide and ketolide antibiotics for the treatment of acute exposure and diseases caused by biodefense pathogens is described.
    Type: Grant
    Filed: October 24, 2009
    Date of Patent: July 7, 2015
    Assignee: CEMPRA PHARMACEUTICALS, INC.
    Inventor: Prabhavathi B. Fernandes
  • Methods for treating resistant diseases using triazole containing macrolides
    Patent number: 8796232
    Abstract: Triazole-containing macrolide and ketolide antibiotics, therapeutic compositions containing them and methods of use for treating diseases caused by one or more resistant organisms are described.
    Type: Grant
    Filed: October 24, 2009
    Date of Patent: August 5, 2014
    Assignee: Cempra Pharmaceuticals, Inc.
    Inventors: Prabhavathi B. Fernandes, David E. Pereira
  • Methods for treating gastrointestinal diseases
    Patent number: 8791080
    Abstract: Described herein are macrolide and ketolide antibiotics and pharmaceutical compositions, methods, and uses thereof for treating gastrointestinal diseases.
    Type: Grant
    Filed: October 24, 2009
    Date of Patent: July 29, 2014
    Assignee: Cempra Pharmaceuticals, Inc.
    Inventor: Prabhavathi B. Fernandes
  • METHODS FOR TREATING GASTROINTESTINAL DISEASES
    Publication number: 20110237534
    Abstract: Described herein are macrolide and ketolide antibiotics and pharmaceutical compositions, methods, and uses thereof for treating gastrointestinal diseases.
    Type: Application
    Filed: October 24, 2009
    Publication date: September 29, 2011
    Applicant: CEMPRA PHARMACEUTICALS, INC.
    Inventor: Prabhavathi B. Fernandes
  • METHODS FOR TREATING RESISTANT DISEASES USING TRIAZOLE CONTAINING MACROLIDES
    Publication number: 20110201566
    Abstract: Triazole-containing macrolide and ketolide antibiotics, therapeutic compositions containing them and methods of use for treating diseases caused by one or more resistant organisms are described.
    Type: Application
    Filed: October 24, 2009
    Publication date: August 18, 2011
    Applicant: CEMPRA PHARMACEUTICALS, INC.
    Inventors: Prabhavathi B. Fernandes, David E. Pereira
  • BIODEFENSES USING TRIAZOLE-CONTAINING MACROLIDES
    Publication number: 20110195920
    Abstract: Use of macrolide and ketolide antibiotics for the treatment of acute exposure and diseases caused by biodefense pathogens is described.
    Type: Application
    Filed: October 24, 2009
    Publication date: August 11, 2011
    Applicant: CEMPRA PHARMACEUTICALS, INC.
    Inventor: Prabhavathi B. Fernandes
  • Co-Administration of Dopamine-Receptor Binding Compounds
    Publication number: 20100041690
    Abstract: Methods for treating a patient having neurological, psychotic, and psychiatric disorders are described comprising the steps of administering to the patient an effective amount of a partial and/or full dopamine D1 receptor agonist, and administering to the patient an effective amount of a dopamine D2 receptor antagonist, Pharmaceutical compositions comprising a dopamine D1 receptor agonist and a dopamine D2 receptor antagonist are also described. The D1 dopamine receptor agonist and the D2 dopamine receptor antagonist can be administered to the patient in the same or in a different composition or compositions.
    Type: Application
    Filed: September 11, 2009
    Publication date: February 18, 2010
    Inventors: Prabhavathi B. Fernandes, Richard Bernard Mailman, David Earl Nichols, Robert Niel Postlethwait
  • Process for detecting proteins specific to hypertension in mammals
    Patent number: 4321120
    Abstract: A process for diagnosing the presence of hypertension or a predisposition to hypertension in a mammal comprises detecting the presence in a body fluid of the mammal of at least one protein associated with hypertension wherein the protein has a relative molecular weight of about 10,000 daltons to about 17,000 daltons. In humans, the process detects the presence of or predisposition to essential hypertension as distinguished from secondary hypertension. A preferred analytical method is discontinuous sodium dodecyl sulfate polyacrylamide gel electrophoresis.
    Type: Grant
    Filed: March 19, 1980
    Date of Patent: March 23, 1982
    Inventors: Ronald V. Nardi, Prabhavathi B. Fernandes